A Web Application for Improving Communication on Hemodialysis Rounds

March 23, 2020 updated by: Stephanie Thompson, University of Alberta

Voicing Individual Concerns for Engagement in Hemodialysis (VOICE-HD): a Web Application for Rounds

To evaluate a web application tool that hemodialysis patients can use outside of dialysis time to log and prioritize their concerns for the nephrologists. Specifically, the investigators will compare the usability of a web application tool to a structured paper form. The investigators will also use data from semi-structured interviews to better understand the experience and acceptability of the web app among patient participants randomized to the web application and among participating nephrologists.

Primary outcome

-Usability (effectiveness, efficiency, satisfaction)

Secondary outcomes

-Quality of the patient-physician interaction (Communication Assessment Tool (CAT-14))

Study Overview

Status

Completed

Conditions

Detailed Description

Usability is defined as Effectiveness (>70%)

  • Number of people submitting a concern/ number of people with opportunity to submit a concern
  • Number of concerns entered/number of times concern was satisfactorily addressed

Efficiency

  • Proportion of non-completed tasks (<70%)
  • The amount of time to complete one concern

Satisfaction

  • Semistructured interviews
  • Usability survey

Study Type

Interventional

Enrollment (Actual)

77

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Edmonton, Alberta, Canada
        • Royal Alexandra Hospital
      • Edmonton, Alberta, Canada
        • University of Alberta Hospital
      • Edmonton, Alberta, Canada
        • Edmonton General Hospital
    • Manitoba
      • Winnipeg, Manitoba, Canada
        • Seven Oaks General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Chronic in-center hemodialysis patients in Edmonton, Alberta and Winnipeg, Manitoba
  • Able to provide consent, understand and read English or have a family member that can do this for them

Exclusion Criteria:

  • Planning to change modality within the next year

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Web-App
A customized web-app tool to be used by patients to communicate concerns to their nephrologist
Cambian IT Health solutions from Surrey BC developed the infrastructure
Active Comparator: Paper
A customized paper tool to be used by patients to communicate concerns to their nephrologist
Contains similar questions to the Web-App tool

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effectiveness - Number of patients submitting a concern divided by the number of patients
Time Frame: 8 weeks
Number of patients submitting a concern divided by the number of patients with an opportunity to submit a concern
8 weeks
Effectiveness - Number of concerns entered divided by the number of concerns that were satisfactorily addressed
Time Frame: 8 weeks
Number of concerns entered divided by the number of concerns that were satisfactorily addressed
8 weeks
Efficiency - The amount of time to complete one concern
Time Frame: 8 weeks
The amount of time to log a concern in the web app
8 weeks
Satisfaction - Usability survey
Time Frame: 8 weeks
Usability survey Defined as greater than 70% of users who agree or strongly agree with the statement on the usability survey. Ranked on a 5 -point Likert scale
8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Communication Assessment Tool
Time Frame: 8 weeks
Items rated from 1 (poor) to 5 (excellent). Published at Makoul et al. Patient Educ Couns 2007
8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Stephanie Thompson, MD PhD, University of Alberta

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 28, 2018

Primary Completion (Actual)

December 12, 2018

Study Completion (Actual)

December 13, 2019

Study Registration Dates

First Submitted

July 18, 2018

First Submitted That Met QC Criteria

July 26, 2018

First Posted (Actual)

July 30, 2018

Study Record Updates

Last Update Posted (Actual)

March 25, 2020

Last Update Submitted That Met QC Criteria

March 23, 2020

Last Verified

March 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • Pro00076483

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodialysis

Clinical Trials on Web-App

3
Subscribe